Symbol
| C3
| contributors: mct - updated : 12-10-2021
|
HGNC name
| complement component 3
|
HGNC id
| 1318
|
corresponding disease(s)
|
C3D
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
| germinal mutation
|  
|  
|  
|
in C3 glomerulopathy | constitutional
|  
|  
|  
|  
|
mitigates the phagocytosis of photoreceptors by macrophages in the outer retina | |
Susceptibility
|
to age-related macular degeneration (ARMD9) to cardiometabolic diseases |
Variant & Polymorphism
other
| R102G polymorphism increases risk of age-related macular degeneration |
|
specific C3 polymorphisms have been shown to predict future cardiovascular events |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
blood | coagulation | | |
C3 binds fibrinogen beta-chain and disruption of fibrinogen-C3 interactionenhances fibrinolysis, which represents a potential novel target tool to reduce thrombosis in high risk individuals |
| | | |